Drug: Ivonescimab Injection

Drug identity checked against registry records

Also recorded as 5-Fluorouracil; Leucovorin; Oxaliplatin

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerNCT07228832Summit TherapeuticsPhase 3Recruiting2028-05-31Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.